HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Edith A Perez Selected Research

taxane

11/2019Trastuzumab emtansine with or without pertuzumab versus trastuzumab with taxane for human epidermal growth factor receptor 2-positive advanced breast cancer: Final results from MARIANNE.
5/2019Relationship between tumor biomarkers and efficacy in MARIANNE, a phase III study of trastuzumab emtansine ± pertuzumab versus trastuzumab plus taxane in HER2-positive advanced breast cancer.
1/2019Correction to: Relationship between tumor biomarkers and efficacy in MARIANNE, a phase III study of trastuzumab emtansine ± pertuzumab versus trastuzumab plus taxane in HER2-positive advanced breast cancer.
9/2017Prolonged survival in patients with breast cancer and a history of brain metastases: results of a preplanned subgroup analysis from the randomized phase III BEACON trial.
1/2017Trastuzumab Emtansine With or Without Pertuzumab Versus Trastuzumab Plus Taxane for Human Epidermal Growth Factor Receptor 2-Positive, Advanced Breast Cancer: Primary Results From the Phase III MARIANNE Study.
1/2017Health-related quality of life in patients with locally recurrent or metastatic breast cancer treated with etirinotecan pegol versus treatment of physician's choice: Results from the randomised phase III BEACON trial.
2/2016N0436 (Alliance): A Phase II Trial of Irinotecan With Cetuximab in Patients With Metastatic Breast Cancer Previously Exposed to Anthracycline and/or Taxane-Containing Therapy.
1/2016PAM50 gene signatures and breast cancer prognosis with adjuvant anthracycline- and taxane-based chemotherapy: correlative analysis of C9741 (Alliance).
11/2015Etirinotecan pegol (NKTR-102) versus treatment of physician's choice in women with advanced breast cancer previously treated with an anthracycline, a taxane, and capecitabine (BEACON): a randomised, open-label, multicentre, phase 3 trial.
7/2015Long-Term Follow-Up of the E1199 Phase III Trial Evaluating the Role of Taxane and Schedule in Operable Breast Cancer.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Edith A Perez Research Topics

Disease

225Breast Neoplasms (Breast Cancer)
07/2022 - 01/2002
121Neoplasms (Cancer)
01/2022 - 01/2002
12Disease Progression
03/2016 - 06/2004
9Cardiotoxicity
04/2022 - 01/2004
9Triple Negative Breast Neoplasms
01/2020 - 01/2010
7Neoplasm Metastasis (Metastasis)
11/2020 - 06/2002
6Heart Failure
12/2017 - 01/2004
6Osteoporosis
03/2016 - 11/2003
5Cardiovascular Diseases (Cardiovascular Disease)
02/2016 - 01/2006
5Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2014 - 10/2003
5Hot Flashes
01/2007 - 03/2002
4Vomiting
07/2022 - 11/2013
4Lung Neoplasms (Lung Cancer)
12/2018 - 01/2003
4Brain Neoplasms (Brain Tumor)
09/2017 - 04/2014
4Metabolic Bone Diseases (Osteopenia)
03/2016 - 08/2006
4Neutropenia
09/2014 - 12/2005
4Leukemia
11/2012 - 01/2003
3Pneumonia (Pneumonitis)
07/2022 - 11/2015
3Diarrhea
07/2022 - 04/2013
3Nausea
07/2022 - 11/2013
3Amenorrhea
02/2022 - 06/2010
3Headache (Headaches)
11/2020 - 12/2007
3Noninfiltrating Intraductal Carcinoma (DCIS)
11/2015 - 05/2013
3Arthralgia (Joint Pain)
08/2015 - 11/2003
3Uterine Hemorrhage (Uterine Bleeding)
04/2013 - 11/2003
3Second Primary Neoplasms (Neoplasms, Second)
08/2006 - 03/2006
2Leukopenia
07/2022 - 04/2014
2Circulating Neoplastic Cells
01/2018 - 11/2011
2Pathologic Complete Response
04/2016 - 06/2010

Drug/Important Bio-Agent (IBA)

68Trastuzumab (Herceptin)FDA Link
07/2022 - 06/2002
34Paclitaxel (Taxol)FDA LinkGeneric
12/2020 - 05/2002
31human ERBB2 proteinIBA
07/2022 - 01/2006
29Doxorubicin (Adriamycin)FDA LinkGeneric
02/2022 - 01/2003
29ErbB Receptors (EGF Receptor)IBA
12/2019 - 09/2004
28AnthracyclinesIBA
04/2022 - 01/2003
27Cyclophosphamide (Cytoxan)FDA LinkGeneric
02/2022 - 01/2003
27taxaneIBA
11/2019 - 01/2003
26Hormones (Hormone)IBA
12/2021 - 11/2003
25Estrogen ReceptorsIBA
08/2017 - 01/2002
25TamoxifenFDA LinkGeneric
11/2015 - 03/2002
20Aromatase InhibitorsIBA
06/2016 - 04/2005
20Letrozole (Femara)FDA LinkGeneric
04/2016 - 11/2003
16Docetaxel (Taxotere)FDA Link
01/2020 - 01/2003
14Lapatinib (GW572016)FDA Link
07/2022 - 03/2008
14Capecitabine (Xeloda)FDA Link
07/2021 - 08/2007
14Proteins (Proteins, Gene)FDA Link
08/2017 - 06/2002
13Taxoids (Taxanes)IBA
02/2011 - 01/2003
11Pharmaceutical PreparationsIBA
12/2018 - 11/2002
10Progesterone Receptors (Progesterone Receptor)IBA
08/2017 - 03/2006
9Biomarkers (Surrogate Marker)IBA
12/2021 - 10/2008
9Zoledronic Acid (Zometa)FDA Link
03/2016 - 08/2006
9Biological ProductsIBA
01/2013 - 03/2006
8Fluorouracil (Carac)FDA LinkGeneric
02/2022 - 01/2003
8Carboplatin (JM8)FDA LinkGeneric
01/2020 - 10/2003
8Ado-Trastuzumab EmtansineIBA
11/2019 - 11/2011
8pertuzumabIBA
11/2019 - 09/2015
8ixabepilone (BMS 247550)FDA Link
09/2017 - 08/2007
7Monoclonal AntibodiesIBA
12/2017 - 01/2004
7Estrogens (Estrogen)FDA Link
03/2016 - 03/2002
7Bevacizumab (Avastin)FDA Link
07/2015 - 12/2007
7RNA (Ribonucleic Acid)IBA
01/2015 - 07/2004
6B 31IBA
12/2019 - 10/2005
6etirinotecan pegolIBA
01/2018 - 11/2013
6ParaffinIBA
11/2015 - 12/2005
6Anastrozole (Arimidex)FDA LinkGeneric
07/2015 - 08/2006
5Epidermal Growth Factor (EGF)IBA
01/2019 - 09/2013
5GemcitabineFDA Link
09/2017 - 06/2002
4Messenger RNA (mRNA)IBA
01/2021 - 04/2012
4Vinorelbine (Navelbine)FDA LinkGeneric
10/2017 - 04/2012
4eribulinFDA Link
09/2017 - 02/2015
4Phenobarbital (Luminal)FDA Link
01/2017 - 11/2011
4Vitamin DFDA LinkGeneric
03/2016 - 03/2009
4exemestane (Aromasin)FDA Link
07/2014 - 08/2006
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
03/2013 - 12/2007
3Tumor Biomarkers (Tumor Markers)IBA
11/2019 - 01/2019
3Tyrosine Kinase InhibitorsIBA
12/2017 - 03/2008
3130-nm albumin-bound paclitaxelIBA
09/2017 - 06/2007
3Fulvestrant (Faslodex)FDA Link
06/2016 - 03/2006
3CalciumIBA
03/2016 - 03/2009
3AlbuminsIBA
07/2015 - 12/2005
3DNA (Deoxyribonucleic Acid)IBA
08/2013 - 10/2008
3Formaldehyde (Formol)FDA Link
01/2013 - 08/2010
3epothilone B (EPO906)IBA
11/2012 - 02/2010
3Albumin-Bound PaclitaxelFDA Link
03/2009 - 10/2005
3Cytochrome P-450 CYP2D6 (CYP2D6)IBA
09/2008 - 12/2005
3Cisplatin (Platino)FDA LinkGeneric
04/2005 - 01/2003
2Epirubicin (Ellence)FDA LinkGeneric
02/2022 - 01/2010
2Protein Kinases (Protein Kinase)IBA
01/2021 - 11/2008
2Topotecan (Hycamtin)FDA LinkGeneric
11/2020 - 08/2010
2Folate Receptor 1IBA
01/2020 - 01/2015
2Methotrexate (Mexate)FDA LinkGeneric
10/2019 - 05/2009

Therapy/Procedure

124Therapeutics
07/2022 - 01/2002
56Drug Therapy (Chemotherapy)
02/2022 - 01/2003
22Adjuvant Chemotherapy
12/2019 - 01/2003
5Aftercare (After-Treatment)
01/2018 - 03/2006
4Neoadjuvant Therapy
12/2018 - 01/2010
4Combination Drug Therapy (Combination Chemotherapy)
10/2017 - 04/2003
4Mastectomy (Mammectomy)
04/2015 - 06/2009
4Radiotherapy
07/2012 - 01/2002
3Segmental Mastectomy (Lumpectomy)
11/2015 - 06/2009